LigoCyte Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.ligocyte.com
Phase 1 Norwalk Vaccine Study
Phase 1
Completed
- Conditions
- Norovirus
- Interventions
- Drug: Adjuvant/ExcipientsBiological: Norwalk VLP VaccineDevice: placebo
- First Posted Date
- 2008-12-11
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- LigoCyte Pharmaceuticals, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT00806962
- Locations
- 🇺🇸
Cincinnati Children's Hospital, Cincinnati, Ohio, United States
🇺🇸University of Maryland Center for Vaccine Development, Baltimore, Maryland, United States
🇺🇸Saint Louis University, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath